Although there are data regarding cell cycle arrest by aromatase inhibitors in breast cancer cells [21], a similar effect was not found with exemestane in NSCLC cell lines in our study (data not shown). The gene discussed is CYP19A1; the disease is non-small cell lung carcinoma.